Aster DM Healthcare Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Aster DM Healthcare’s Q3 results FY26 are scheduled to be announced on 30th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Aster DM Healthcare Q3 Results 2026 Preview

• Aster DM Healthcare’s revenue is expected to be in the range of ₹1,049.82 crore, a 3.37% YoY decrease. 
• Profit After Tax, or PAT, is projected to fall by 41.36% YoY. 
• Aster DM Healthcare’s EBITDA is expected to fall to ₹103.25 crore. 
• Net profit is ₹56.79 crore, a fall 41.36% YoY 

Aster DM Healthcare Share Performance 

• Over the past six months, Aster DM Healthcare’s share price has fallen by 8.95% to ₹538.65.
• Moreover, over the past year, the stock has increased by 12.87%.
• Despite this weak short-term performance, Aster DM Healthcare’s stock has delivered a financially sound 239.85% return over the past 5 years.
• As of 29th January 2026, the stock traded at ₹538.05 per share.

Key Factors to Watch for Aster DM Healthcare Q3 Results FY26 

• Revenue growth and core hospital demand – Trends in overall sales driven by inpatient volumes, outpatient services, and case mix will reflect demand momentum across the network.
• Operating margins and profitability – Movement in EBITDA and net profit margins will signal cost efficiency and pricing power, especially amid cost control and improved occupancy.
• Capacity utilisation and expansion metrics – Performance of existing beds and contribution from newly added capacity, as well as progress on planned bed additions, will be key for the medium‑term growth outlook.
• Average revenue per occupied bed (ARPOB) and length of stay – ARPOB trends and changes in average length of stay indicate service mix quality and operational efficiency.
• Merger integration & strategic developments – Updates on the Quality Care India Ltd merger, synergies from combined operations, and any regulatory progress will influence future scale and performance.

Final Thoughts

Aster DM Healthcare will announce its Q3 FY26 results on 30th January 2026. Analysts expect 5.27% YoY revenue growth, a 0.95% fall in PAT, and a 5.99% fall in EBITDA. Aster DM Healthcare focuses on expanding hospital and clinic networks, increasing patient volumes, improving operational efficiencies, growing the pharmacy and diagnostics segments, and enhancing digital healthcare services across domestic and international markets.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here